Glucagon-like peptide-1 regulates calcium homeostasis and electrophysiological activities of HL-1 cardiomyocytes

Jen Hung Huang, Yao Chang Chen, Ting I. Lee, Yu Hsun Kao, Tze Fan Chazo, Shih Ann Chen, Yi Jen Chen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Glucagon like-peptide-1 (GLP-1) is an incretin hormone with antidiabetic effects through stimulating insulin secretion, β cell neogenesis, satiety sensation, and inhibiting glucagon secretion. Administration of GLP-1 provides cardioprotective effects through attenuating cardiac inflammation and insulin resistance. GLP-1 also modulates the heart rate and systolic pressure, which suggests that GLP-1 may have cardiac electrical effects. Therefore, the purposes of this study were to evaluate whether GLP-1 has direct cardiac effects and identify the underlying mechanisms. Patch clamp, confocal microscopy with Fluo-3 fluorescence, and Western blot analyses were used to evaluate the electrophysiological characteristics, calcium homeostasis, and calcium regulatory proteins in HL-1 atrial myocytes with and without GLP-1 (1 and 10 nM) incubation for 24 h. GLP-1 (1 and 10 nM) and control cells had similar action potential durations. However, GLP-1 at 10 nM significantly increased calcium transients and sarcoplasmic reticular Ca2+ contents. Compared to the control, GLP-1 (10 nM)-treated cells significantly decreased phosphorylation of the ryanodine receptor at S2814 and total phospholamban, but there were similar protein levels of sarcoplasmic reticular Ca2+-ATPase and the sodium-calcium exchanger. Moreover, exendin (9-39) amide (a GLP-1 receptor antagonist, 10 nM) attenuated GLP-1-mediated effects on total SR content and phosphorylated ryanodine receptor S2814. This study demonstrates GLP-1 may regulate HL-1 cell arrhythmogenesis through modulating calcium handling proteins.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalPeptides
Volume78
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Glucagon-Like Peptide 1
Cardiac Myocytes
Homeostasis
Calcium
Ryanodine Receptor Calcium Release Channel
Sodium-Calcium Exchanger
Insulin
Incretins
Phosphorylation
Proteins
Calcium-Transporting ATPases
Confocal microscopy
Clamping devices
Glucagon
Hypoglycemic Agents
Confocal Microscopy
Muscle Cells
Action Potentials
Insulin Resistance
Heart Rate

Keywords

  • Atrial arrhythmogenesis
  • Calcium handling protein
  • Glucagon like-peptide-1
  • Ryanodine receptor

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Glucagon-like peptide-1 regulates calcium homeostasis and electrophysiological activities of HL-1 cardiomyocytes. / Huang, Jen Hung; Chen, Yao Chang; Lee, Ting I.; Kao, Yu Hsun; Chazo, Tze Fan; Chen, Shih Ann; Chen, Yi Jen.

In: Peptides, Vol. 78, 01.04.2016, p. 91-98.

Research output: Contribution to journalArticle

@article{ca4bf5b676db4334ab2af1bcf9667f06,
title = "Glucagon-like peptide-1 regulates calcium homeostasis and electrophysiological activities of HL-1 cardiomyocytes",
abstract = "Glucagon like-peptide-1 (GLP-1) is an incretin hormone with antidiabetic effects through stimulating insulin secretion, β cell neogenesis, satiety sensation, and inhibiting glucagon secretion. Administration of GLP-1 provides cardioprotective effects through attenuating cardiac inflammation and insulin resistance. GLP-1 also modulates the heart rate and systolic pressure, which suggests that GLP-1 may have cardiac electrical effects. Therefore, the purposes of this study were to evaluate whether GLP-1 has direct cardiac effects and identify the underlying mechanisms. Patch clamp, confocal microscopy with Fluo-3 fluorescence, and Western blot analyses were used to evaluate the electrophysiological characteristics, calcium homeostasis, and calcium regulatory proteins in HL-1 atrial myocytes with and without GLP-1 (1 and 10 nM) incubation for 24 h. GLP-1 (1 and 10 nM) and control cells had similar action potential durations. However, GLP-1 at 10 nM significantly increased calcium transients and sarcoplasmic reticular Ca2+ contents. Compared to the control, GLP-1 (10 nM)-treated cells significantly decreased phosphorylation of the ryanodine receptor at S2814 and total phospholamban, but there were similar protein levels of sarcoplasmic reticular Ca2+-ATPase and the sodium-calcium exchanger. Moreover, exendin (9-39) amide (a GLP-1 receptor antagonist, 10 nM) attenuated GLP-1-mediated effects on total SR content and phosphorylated ryanodine receptor S2814. This study demonstrates GLP-1 may regulate HL-1 cell arrhythmogenesis through modulating calcium handling proteins.",
keywords = "Atrial arrhythmogenesis, Calcium handling protein, Glucagon like-peptide-1, Ryanodine receptor",
author = "Huang, {Jen Hung} and Chen, {Yao Chang} and Lee, {Ting I.} and Kao, {Yu Hsun} and Chazo, {Tze Fan} and Chen, {Shih Ann} and Chen, {Yi Jen}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.peptides.2016.02.007",
language = "English",
volume = "78",
pages = "91--98",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Glucagon-like peptide-1 regulates calcium homeostasis and electrophysiological activities of HL-1 cardiomyocytes

AU - Huang, Jen Hung

AU - Chen, Yao Chang

AU - Lee, Ting I.

AU - Kao, Yu Hsun

AU - Chazo, Tze Fan

AU - Chen, Shih Ann

AU - Chen, Yi Jen

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Glucagon like-peptide-1 (GLP-1) is an incretin hormone with antidiabetic effects through stimulating insulin secretion, β cell neogenesis, satiety sensation, and inhibiting glucagon secretion. Administration of GLP-1 provides cardioprotective effects through attenuating cardiac inflammation and insulin resistance. GLP-1 also modulates the heart rate and systolic pressure, which suggests that GLP-1 may have cardiac electrical effects. Therefore, the purposes of this study were to evaluate whether GLP-1 has direct cardiac effects and identify the underlying mechanisms. Patch clamp, confocal microscopy with Fluo-3 fluorescence, and Western blot analyses were used to evaluate the electrophysiological characteristics, calcium homeostasis, and calcium regulatory proteins in HL-1 atrial myocytes with and without GLP-1 (1 and 10 nM) incubation for 24 h. GLP-1 (1 and 10 nM) and control cells had similar action potential durations. However, GLP-1 at 10 nM significantly increased calcium transients and sarcoplasmic reticular Ca2+ contents. Compared to the control, GLP-1 (10 nM)-treated cells significantly decreased phosphorylation of the ryanodine receptor at S2814 and total phospholamban, but there were similar protein levels of sarcoplasmic reticular Ca2+-ATPase and the sodium-calcium exchanger. Moreover, exendin (9-39) amide (a GLP-1 receptor antagonist, 10 nM) attenuated GLP-1-mediated effects on total SR content and phosphorylated ryanodine receptor S2814. This study demonstrates GLP-1 may regulate HL-1 cell arrhythmogenesis through modulating calcium handling proteins.

AB - Glucagon like-peptide-1 (GLP-1) is an incretin hormone with antidiabetic effects through stimulating insulin secretion, β cell neogenesis, satiety sensation, and inhibiting glucagon secretion. Administration of GLP-1 provides cardioprotective effects through attenuating cardiac inflammation and insulin resistance. GLP-1 also modulates the heart rate and systolic pressure, which suggests that GLP-1 may have cardiac electrical effects. Therefore, the purposes of this study were to evaluate whether GLP-1 has direct cardiac effects and identify the underlying mechanisms. Patch clamp, confocal microscopy with Fluo-3 fluorescence, and Western blot analyses were used to evaluate the electrophysiological characteristics, calcium homeostasis, and calcium regulatory proteins in HL-1 atrial myocytes with and without GLP-1 (1 and 10 nM) incubation for 24 h. GLP-1 (1 and 10 nM) and control cells had similar action potential durations. However, GLP-1 at 10 nM significantly increased calcium transients and sarcoplasmic reticular Ca2+ contents. Compared to the control, GLP-1 (10 nM)-treated cells significantly decreased phosphorylation of the ryanodine receptor at S2814 and total phospholamban, but there were similar protein levels of sarcoplasmic reticular Ca2+-ATPase and the sodium-calcium exchanger. Moreover, exendin (9-39) amide (a GLP-1 receptor antagonist, 10 nM) attenuated GLP-1-mediated effects on total SR content and phosphorylated ryanodine receptor S2814. This study demonstrates GLP-1 may regulate HL-1 cell arrhythmogenesis through modulating calcium handling proteins.

KW - Atrial arrhythmogenesis

KW - Calcium handling protein

KW - Glucagon like-peptide-1

KW - Ryanodine receptor

UR - http://www.scopus.com/inward/record.url?scp=84959557831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959557831&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2016.02.007

DO - 10.1016/j.peptides.2016.02.007

M3 - Article

C2 - 26930508

AN - SCOPUS:84959557831

VL - 78

SP - 91

EP - 98

JO - Peptides

JF - Peptides

SN - 0196-9781

ER -